千金药业
(600479)
| 流通市值：48.63亿 | | | 总市值：57.19亿 |
| 流通股本：4.19亿 | | | 总股本：4.92亿 |
| 利润表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 营业总收入 | 1,918,299,373.44 | 970,265,534.34 | 3,628,843,106.61 | 2,718,335,546.6 |
| 营业总成本 | 1,706,645,826.09 | 883,983,897.86 | 3,248,878,976.3 | 2,458,728,936.98 |
| 其他经营收益 | | | | |
| 营业利润 | 234,122,583.88 | 97,400,505.55 | 437,251,748.38 | 300,588,151.65 |
| 利润总额 | 232,592,157.43 | 96,556,688.63 | 435,101,679.78 | 298,712,363.67 |
| 净利润 | 199,899,671.27 | 84,191,940.58 | 375,670,800.76 | 258,232,870.24 |
| 每股收益 | | | | |
| 其他综合收益 | 579.95 | -458.94 | 183,896.35 | 524,130.45 |
| 综合收益总额 | 199,900,251.22 | 84,191,481.64 | 375,854,697.11 | 258,757,000.69 |
| 资产负债表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 流动资产: | | | | |
| 流动资产合计 | 2,231,637,350.11 | 2,333,399,956.53 | 2,163,595,082.18 | 2,160,331,768.84 |
| 非流动资产: | | | | |
| 非流动资产合计 | 2,766,824,537.24 | 2,800,429,106.28 | 2,800,082,216.35 | 2,740,587,670.74 |
| 资产总计 | 4,998,461,887.35 | 5,133,829,062.81 | 4,963,677,298.53 | 4,900,919,439.58 |
| 流动负债: | | | | |
| 流动负债合计 | 1,536,790,692.1 | 1,579,045,589.59 | 1,491,107,809.28 | 1,540,001,752.77 |
| 非流动负债: | | | | |
| 非流动负债合计 | 113,268,457.27 | 120,430,698.74 | 122,408,196.41 | 116,516,690.39 |
| 负债合计 | 1,650,059,149.37 | 1,699,476,288.33 | 1,613,516,005.69 | 1,656,518,443.16 |
| 所有者权益(或股东权益): | | | | |
| 归属于母公司股东权益合计 | 3,022,147,548.07 | 3,103,313,823.14 | 3,028,298,496.58 | 2,501,527,329.33 |
| 股东权益合计 | 3,348,402,737.98 | 3,434,352,774.48 | 3,350,161,292.84 | 3,244,400,996.42 |
| 负债和股东权益合计 | 4,998,461,887.35 | 5,133,829,062.81 | 4,963,677,298.53 | 4,900,919,439.58 |
| 现金流量表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 经营活动产生的现金流量: | | | | |
| 经营活动现金流入小计 | 2,029,009,903.15 | 935,489,124.93 | 3,859,534,250.82 | 2,918,990,251.21 |
| 经营活动现金流出小计 | 1,975,944,064.77 | 1,037,142,688.43 | 3,379,289,283.45 | 2,676,021,875.31 |
| 经营活动产生的现金流量净额 | 53,065,838.38 | -101,653,563.5 | 480,244,967.37 | 242,968,375.9 |
| 投资活动产生的现金流量: | | | | |
| 投资活动现金流入小计 | 63,637,477.41 | 30,011,818.63 | 11,472,843.39 | 4,119,450 |
| 投资活动现金流出小计 | 32,098,111.33 | 23,081,486.44 | 942,473,337.21 | 862,847,063.8 |
| 投资活动产生的现金流量净额 | 31,539,366.08 | 6,930,332.19 | -931,000,493.82 | -858,727,613.8 |
| 筹资活动产生的现金流量: | | | | |
| 筹资活动现金流入小计 | 119,455,205.99 | - | 134,522,366.25 | 5,594,632.23 |
| 筹资活动现金流出小计 | 233,813,037.38 | 2,560 | 283,518,398.95 | 175,569,371.81 |
| 筹资活动产生的现金流量净额 | -114,357,831.39 | -2,560 | -148,996,032.7 | -169,974,739.58 |
| 汇率变动对现金及现金等价物的影响 | - | - | - | - |
| 现金及现金等价物净增加额 | -29,752,626.93 | -94,725,791.31 | -599,751,559.15 | -785,733,977.48 |
| 期末现金及现金等价物余额 | 706,290,564.42 | 641,317,400.04 | 736,043,191.35 | 550,060,773.02 |
| 补充资料: | | | | |
| 现金及现金等价物的净增加额 | -29,752,626.93 | - | -599,751,559.15 | - |
最新报告期：2026-09-02| 研究机构 | 分析师 | 预测每股收益(元) | 更新日 |
| 2026年 | 2027年 | 2028年 |
| 招商证券 | 梁广楷,欧阳京,许菲菲 | 0.77 | 0.89 | 1.02 | 2026-09-02 |